Caliber Imaging & Diagnostics has named Richard C. Christopher as Chief Financial Officer, effective immediately. Mr. Christopher replaces Richard J. Pulsifer. Mr. Christopher served for eight years as Chief Financial Officer of DUSA Pharmaceuticals, Inc., until its sale to Sun Pharmaceuticals Industries Limited in 2012.
Caliber Imaging & Diagnostics, Inc.
Equities
LCDX
US13001C1053
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2022 | VivaScope GmbH signed a definitive agreement to acquire Caliber Imaging & Diagnostics, Inc.. | CI |
2021 | Saudi PIF nearly triples U.S. stock holdings; adds Walmart, Pinterest | RE |
1st Jan change | Capi. | |
---|---|---|
-.--% | 857 | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.37% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- LCDX Stock
- News Caliber Imaging & Diagnostics, Inc.
- Caliber Imaging & Diagnostics Announces Executive Change